Finoriq research workspace

FIREFLY NEUROSCIENCE, INC. (AIFF) Company Overview

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes. Review AIFF filings, fundamentals, valuation, and ownership on Finoriq.

Company Snapshot

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Company

FIREFLY NEUROSCIENCE, INC. (AIFF)

Ticker

AIFF

Market Cap

$17.6M

Latest Price

$1.13

Industry

Software

Open insider transactions

FIREFLY NEUROSCIENCE, INC. (AIFF) Current Valuation Metrics

Static valuation preview for FIREFLY NEUROSCIENCE, INC. (AIFF). Market data retrieved 2026-07-09. Filing currency USD.

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.